Abstract:Purpose: The aim of the present study was to establish a liquid chromatography–tandem mass spectrometry (LC-MS/MS) method for the determination of SHR9146, a novel IDO1/TDO dual inhibitor, in mouse plasma and tissues, and to apply it to investigate the preclinical plasma pharmacokinetics and tissue distribution of SHR9146 in mice. Methods: Samples were spiked with deuterated SHR9146-d 4 as an internal standard and pretreated by protein-precipitation extraction with methanol. Chromatographic separation was performed on a Venusil ABS C18 column (150 × 4.6 mm, 5 μm) by isocratic elution with 10 mM ammonium acetate buffer containing 0.1% formic acid solution and methanol as mobile phases. MS detection was conducted in positive electrospray ionization with multiple reaction monitoring at m/z 444.1/229.4 for SHR9146 and m/z 448.4/229.2 for the internal standard. Results: The method showed good linearity in the calibration range from 0.05 to 50.0 μg/mL. Precisions (intra- and inter-run) were in the range from 0.5% to 5.1%, and accuracies (RE) were between −3.0% and 4.4% for all the concentration levels. SHR9146 was stable in all the tested bio-samples with recoveries >90%. Pharmacokinetic parameters were obtained by non-compartmental analysis. SHR9146 has a half-life of 0.713 h when IV-injected, with CL 12 mL/min/kg and Vd 0.666 L/kg. After oral dosing from 20 to 80 mg/kg, Cmax (range from 8.751 to 12.893 μg/mL) and AUC 0-t (range from 15.606 to 69.971 μg·h/mL) of SHR9146 showed dose proportionality. Other post-oral pharmacokinetic parameters in plasma were as follows ( n =6): Tmax 0.79 ± 0.36 h, t 1/2 1.586 ± 0.853 h, CL 19.8 ± 0.9 mL/min/kg, Vd 3.427± 1.617 L/kg, and absolute bioavailability of 54.2% ± 12.6% (range from 40.2% to 64.7%). In addition, SHR9146 was found to be absorbed rapidly and distributed widely and mainly in the stomach, adrenal gland, liver, and lung. Conclusion: The method was simple, sensitive, accurate, and specific and was successfully applied for the preclinical pharmacokinetic and tissue distribution study of SHR9146 in mice. The results showed that SHR9146 had dose-independent kinetics in mice via oral administration and was absorbed rapidly and distributed widely. The study provides a good basis for further drug development assessment.

Determination of oridonin in mice liver following tail intravenous injection of oridonin solid liposome nanoparticles by HPLC

Studies on Determination and in Vitro Metabolism of Ginkgolides and Bilobalide in Rat Liver Microsomes by Using HPLC-ELSD Method

RP-HPLC DETERMINATION OF DIPHENYTRIAZOL IN RAT LIVER MICROSOMAL INCUBATES AND ITS APPLICATION IN IN VITRO METABOLISM

Determination of doxorubicin in plasma and tissues of mice by UPLC-MS/MS and its application to pharmacokinetic study

Determination of trans-resveratrol in mouse liver by high performance liquid chromatography

Quantitative Determination of Oridonin in Isodon Macrophyllus by RP-HPLC

In Vitro and in Vivo Studies of Galactose-Modified Liver-Targeting Liposomes.

Determination of the endogenous OATP1B biomarkers glycochenodeoxycholate-3-sulfate and chenodeoxycholate-24-glucuronide in human and mouse plasma by a validated UHPLC-MS/MS method

Determination of Curcumin in Plasma by HPLC and Its Pharmacokinetics in Mice

Determination of related substances in Ornidazole injection by HPLC

Study on Tissue Distribution of Emodin Solid Lipid Nanoparticles in Mice

HPLC Determination of 1,3 - Diphenyl - 1,3 - Propanedione in Mouse Plasma and Its Application to Pharmacokinetic Study

Determination of 2-Amino-6-cyclopropylamino-9-(2,3-dideoxy-β-d-glyceropent-2-enofuranosyl)purine in Rat Plasma, Urine and Liver Homogenates by High Performance Liquid Chromatography

Preclinical PK investigation of a novel IDO1/TDO dual inhibitor—SHR9146 in mouse plasma and tissues by LC-MS/MS

Pharmacokinetics and tissue distribution study of orientin in rat by liquid chromatography

Development of High Performance Liquid Chromatography Method for Costunolide and Dehydrocostuslactone in Mice Plasma and Tissues: Application to Pharmacokinetic Study

In Vivo Studies On The Oridonin-Loaded Nanostructured Lipid Carriers

Dose-response of Oridonin on Hepatic Cytochromes P450 Mrna Expression and Activities in Mice.

Determination of Dehydrodiisoeugenol in Rat Tissues Using HPLC Method

Determination of Colchicine in Mouse Plasma by High Performance Liquid-chromatographic Method with UV Detection and Its Application to Pharmacokinetic Studies

Determination of Oleanolic Acid in Rat Plasma by HPLC-MS